When his father was diagnosed with Lou Gehrig’s disease in 2000, Daniel Doctoroff thought it was just a case of horrible bad luck. But when his uncle got the same staggering diagnosis seven years later, Doctoroff realized that he and his family probably had a genetic propensity for the illness.

There are no effective treatments for the disease, formally called amyotrophic lateral sclerosis, or ALS, which killed the two brothers. So Doctoroff has opted not to take a DNA test to see if he inherited a mutation that causes a minority of cases. But he also refused to simply live under a sword of Damocles.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy